View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Financials Research ... (+6)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland
  • Magnus Andersson
  • Patrik Brattelius
  • Simon Brun
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye

Elekta AB: 1 director

A director at Elekta AB bought 113,633 shares at 48.343SEK and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013597476 of NOK 100,000,000. Start date: 19 June, 2025Maturity: 19 September, 2025Coupon: 4.78 %Organised by: DNB CarnegieSarpsborg, 17 June 2025 Contact:Director Investor Relations, Knut-Harald Bakke, This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

 PRESS RELEASE

Borregaard ASA: Change in Group Executive Management

Borregaard ASA: Change in Group Executive Management Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August (see stock exchange release dated 23 May 2025). Bakke currently serves as Director of Investor Relations and has previously held the position of Energy Director at Borregaard. Prior to joining the company in 2019, he held senior leadership roles at Norsk Hydro, where he was responsible for global energy market o...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson
ABGSC Financials Research ... (+4)
  • ABGSC Financials Research
  • Jan Erik Gjerland
  • Magnus Andersson
  • Patrik Brattelius
Marine Leleux ... (+3)
  • Marine Leleux
  • Maureen Schuller
  • Suvi Platerink Kosonen

Bank Brunch/BYLAN USD covered, Swedbank, first bank CSRD disclosures, ...

Bayerische Landesbank back after a decade in USD covered, Swedbank: lower excess capital may open up room for Tier 2 issuance, Banks' first CSRD disclosures: it's a messy start, ECB warns, again, about private markets interconnectedness with banks

Marine Leleux ... (+3)
  • Marine Leleux
  • Maureen Schuller
  • Suvi Platerink Kosonen

Bank Brunch/BYLAN USD covered, Swedbank, first bank CSRD disclosures, ...

Bayerische Landesbank back after a decade in USD covered, Swedbank: lower excess capital may open up room for Tier 2 issuance, Banks' first CSRD disclosures: it's a messy start, ECB warns, again, about private markets interconnectedness with banks.

ABGSC Financials Research ... (+4)
  • ABGSC Financials Research
  • Jan Erik Gjerland
  • Magnus Andersson
  • Patrik Brattelius
ABGSC Financials Research ... (+4)
  • ABGSC Financials Research
  • Jan Erik Gjerland
  • Magnus Andersson
  • Patrik Brattelius
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch